EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE .

Autor: I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 4, Iss 3, Pp 111-128 (2016)

Externí odkaz: https://doaj.org/article/2a552d900231463692bc9e47958d816c

Vericiguat in heart failure: From scientific evidence to clinical practice

Autor: J R, González-Juanatey, M, Anguita-Sánchez, A, Bayes-Genís, J, Comín-Colet, A, García-Quintana, A, Recio-Mayoral, J L, Zamorano-Gómez, J M, Cepeda-Rodrigo, L, Manzano

Publikováno v: Revista Clinica Espanola
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
REVISTA CLINICA ESPANOLA
r-FISABIO. Repositorio Institucional de Producción Científica

Despite currently available treatments, risk of death and hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF) remains high. The pathophysiology of HFrEF includes neurohormonal activation characterized by stimulation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960bedf296e9273bf0f60e95c2d4fc3e
https://doi.org/10.1016/j.rceng.2021.12.006

Why does CRT work better in women?

Autor: A Lorente Ros, J M Monteagudo, V Calvi, M J Sancho-Tello, A H Maass, L Van Erven, S Ellery, M Nurnberg, G Voros, K Vernooy, A Quesada, J G Martinez, E Nof, J M Tolosana, J L Zamorano Gomez

Publikováno v: European Heart Journal. 43

Introduction It has been recently postulated that cardiac resynchronization therapy (CRT) might have a higher efficacy in women, with a greater reverse cardiac remodeling in this population. The reasons for these differences are not yet completely un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8a531b9178aeee199d28e79411be57e
https://doi.org/10.1093/eurheartj/ehac544.2498

STREI: a new index of right heart function in isolated severe tricuspid regurgitation by Speckle tracking Echocardiography

Autor: R Hinojar Baydes, C Fernandez-Golfin, A Gonzalez-Gomez, A Garcia-Martin, J M Monteagudo, I Garcia-Lunar, S Rivas, M A Sanroman, A Pardo, A Sanchez-Recalde, J L Zamorano

Publikováno v: European Heart Journal. 43

Background Right ventricular (RV) performance is key in the management of patients with severe tricuspid regurgitation (TR); detection of RV dysfunction is crucial to identify on time patients that benefit from valve intervention. Conventional parame

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::526368f003984e26f6844c9beed5a81b
https://doi.org/10.1093/eurheartj/ehac544.139

Transcatheter tricuspid annuloplasty with band implantation and its safety profile: a single-center experience

Autor: R R Martinez Moya, R Ortega Perez, A Pardo Sanz, L Salido Tahoces, A Sanchez Recalde, M Abellas Sequeiros, J L Mestre Barcelo, C Fernandez Golfin, A Garcia Martin, R Hinojar Baydes, S Rivas Garcia, H Manjon Rubio, J L Zamorano Gomez

Publikováno v: European Heart Journal. 43

Introduction Severe tricuspid regurgitation is a prevalent valve disease with a negative impact on the prognosis and quality of life of patients. Transcatheter tricuspid annuloplasty with band implantation is an alternative for the treatment of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa72717f44f9ea31a55936366cea7633
https://doi.org/10.1093/eurheartj/ehac544.2128